1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. BIORESTORATIVE THERAPIES INC
BioRestorative Therapies Inc
XNAS: BRTX
Download real time
2.240.10(4.67%)
New 52W Low today
85,220
XNAS Volume
High volume today

XNAS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for BioRestorative Therapies Inc is on 07 Oct 2026 for the purpose of BioRestorative Therapies Inc Second Quarter Earnings Results for 2026See details

BioRestorative Therapies Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for BioRestorative Therapies Inc share price target, revenues, EPS, net income and more

BioRestorative Therapies Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEGATIVE

    Quarterly Revenue BioRestorative Therapies Inc Mar-2026 Quarterly Revenue is $0 Million which is growth of -7.3% YoY.

  • POSITIVE

    Quarterly Net Profit BioRestorative Therapies Inc Mar-2026 Quarterly Net Profit is $-2 Million which is growth of 59.7% YoY.

BioRestorative Therapies Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphMar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23
Operating Rev.
0000.3000.20.10000.10
Cost Of Rev.
00000-----
Gross Profit
000.3000.20.1-----
⌄
3.43.83.73.64.82.72.52.64.13.23.13.25.8
Operating Profit
-3.4-3.8-3.7-3.3-4.8-2.7-2.3-2.5-4.1-3.2-3-3.1-5.8
⌄
000.10.10.10.10.20.20.20.40.10.10
Profit Before Tax
-2.2-3.2-3-2.7-5.3-1.6-1.1-4-2.2-2.8-2.9-3-5.7
Tax
-------------
⌄
-2.2-3.2-3-2.7-5.3-1.6-1.1-4-2.2-2.8-2.9-3-5.7
Diluted NI Avail to Com Stockholders Ann.
-2.2-3.2-3-2.7-5.3-1.6-1.1-4-2.2-2.8-2.9-3-5.7
Basic EPS
-2.4-6.4-6.6-6-12.8-4-2.6-10-6.6-11.4-12.8-15.4-30.6
Diluted EPS After ExtraOrdinary
-3.8-7.6-7.9-7.3-11.3-6.3-5.2-5.7-11.3-11.4-12.8-15.4-30.6
Number Of Shares End
0.90.50.50.40.40.40.40.40.30.20.20.20.2
Net Income Continuing Discontinued Operations
-2.2-3.2-3-2.7-5.3-1.6-1.1-4-2.2-2.8-2.9-3-5.7
Normalized Income
-3.4-3.8-3.7-3.2-4.7-2.6-2.1-2.3-3.8-2.8-2.9-3-5.7
Interest Income
000.10.10.10.10.20.20.2----
Interest
-------------
Net Interest Income
000.10.10.10.10.20.20.20.40.10.10
EBIT
-3.4-3.8-3.7-3.3-4.8-2.7-2.3-2.5-4.1-3.2-3-3.1-5.8
EBITDA
-3.3-3.8-3.7-3.3-4.8-2.6-2.2-2.4-4.1-3.2-3-3.1-5.7
Reconciled Cost Of Rev.
00000-----
Reconciled Depr.
0.10.10.10.10.10.10.10.100000
Profit From Continuing Operations
-2.2-3.2-3-2.7-5.3-1.6-1.1-4-2.2-2.8-2.9-3-5.7
Normalized EBITDA
-4.6-4.3-4.3-3.8-4.1-3.6-3.3-0.7-5.6-3.2-3-3.1-5.7
*All financials are in USD Million and price data in USD
Add metric to table
Search...

BioRestorative Therapies Inc competitor comparison and performance snapshot within industry

BioRestorative Therapies Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Annual Revenue BioRestorative Therapies Inc Dec-2025 Annual Revenue is $0 Million which is growth of -10.3% YoY.

  • NEGATIVE

    Annual Net Profit BioRestorative Therapies Inc Dec-2025 Annual Net Profit is $-14 Million which is growth of -58.6% YoY.

BioRestorative Therapies Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
58.7%
32%
 0.40.40.20.10.10.10.10.10.100.6
Cost Of Rev. Ann.
-
-
000------0.3
Gross Profit Ann.
-
-
0.30.30.4------0.100.4
Operating Exp. Ann.
-5.6%
41.7%
14.61611.915.31926.42.88.67.88.57.87.5
Operating Profit Ann.
-
-
-14.2-15.7-11.6-15.1-18.9-26.3-2.8-8.4-7.7-8.4-7.8-7.2
⌄
-
-
0.20.30.60.60-1.8-1.6-5.1-3.2-1.1-0.8-0.3
Other Exp. Ann.
40.1%
-
 1.120.20.4-16.2-6.9-1.1-1.70-0.1-0.5
PBT Ann.
-
-
-11.1-14.2-9-14.4-18.5-44.3-11.3-14.7-12.5-9.4-8.6-7.9
Tax Ann.
-
-
 -----------
⌄
-
-
-11.1-14.2-9-14.4-18.5-44.3-11.3-14.7-12.5-9.4-8.6-7.9
Diluted NI Avail to Com Stockholders Ann.
-
-
-11.1-14.2-9-14.4-18.5-44.3-11.3-14.7-12.5-9.4-8.6-7.9
EPS Ann.
-
-
 -31.6-23.2-68.4-102.2-746-315.1-15,054.4-85,738.4-124,271.8-148,901.6-193,255.6
Diluted EPS Ann.
-
-
 -31.6-23.2-68.4-102.2-746-315.1-15,054.4-85,738.4-124,271.8-148,901.6-193,255.6
Number Of Shares End
35.7%
-
 0.50.40.20.20.20
Total Exp. Ann.
-5.6%
41.7%
 161215.31926.42.88.67.88.57.87.8
Net Income Continuing Discontinued Operations Ann.
-
-
-11.1-14.2-9-14.4-18.5-44.3-11.3-14.7-12.5-9.4-8.6-7.9
Normalized Income Ann.
-
-
-14-15.4-10.8-14.4-18.7-44.3-5.1-15.4-12.3-9.5-8.6-7.4
Interest Income Ann.
-
-
0.20.30.60.6--------
Interest Ann.
-
-
 ----1.81.65.13.21.10.80.3
EBITDA Ann.
-
-
-14-15.4-11.4-15-18.7-42.4-9.5-9.3-9.1-8.1-7.6-7.5
Reconciled Cost Of Rev. Ann.
-
-
000------0.3
Reconciled Depr. Ann.
26%
14.9%
0.20.20.20.20.10.10.10.20.20.30.30.2
Profit From Continuing Operations Ann.
-
-
-11.1-14.2-9-14.4-18.5-44.3-11.3-14.7-12.5-9.4-8.6-7.9
Normalized EBITDA Ann.
-
-
-17-16.6-13.2-15-19-42.4-3.3-10.1-8.8-8.2-7.6-7
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
2Y CAGR
41.4%
3Y CAGR
58.7%
5Y CAGR
32%
7Y CAGR
21.9%
10Y CAGR
-4%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
34.5%
2Y CAGR
2.3%
3Y CAGR
-5.6%
5Y CAGR
41.7%
7Y CAGR
10.8%
10Y CAGR
7.9%
Operating Expenses Annual Cr growth is stable compared to historical averages.

BioRestorative Therapies Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund BioRestorative Therapies Inc Dec-2025 Total Shareholders Fund is $0 Million which is growth of -96.0% YoY.

  • NEGATIVE

    Total Assets BioRestorative Therapies Inc Dec-2025 Total Assets is $4 Million which is growth of -66.8% YoY.

BioRestorative Therapies Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-37%
-1.4%
4.112.312.616.422.54.41.51.21.81.62
⌄
83.4%
-8.3%
3.73.81.10.60.95.714.29.88.66.65.9
⌄
-73.3%
-
0.38.511.515.821.6-1.3-12.8-8.6-6.8-5-3.9
Total Capitalization Ann.
-70.6%
-32.7%
0.48.511.615.821.82.9-12.8-8.1-6.6-4.7-3.6
Tangible Assets Ann.
-
-
-0.27.910.81521-2-13.5-9.5-7.7-6-5
Working Capital Ann.
-
-
-0.67.410.314.721.12.1-13.7-9.1-7.8-5.8-5.3
Invested Capital Ann.
-73.3%
-36.5%
0.38.511.515.821.82.9-5.6-4.5-3.2-2.8-2.6
Tangible Book Value Ann.
-
-
-0.27.910.81521-2-13.5-9.5-7.7-6-5
Borrowings Ann.
-
-
-0.20.30.74.87.84.23.72.21.3
Net Debt Ann.
-
-
-----1.27.143.22.11.2
Share Issued Ann.
26%
-
0.40.40.20.20.20
Number Of Shares End
35.7%
-
0.50.40.20.20.20
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-66.7%
2Y CAGR
-43%
3Y CAGR
-37%
5Y CAGR
-1.4%
7Y CAGR
19.2%
10Y CAGR
7.4%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-2.6%
2Y CAGR
83.4%
3Y CAGR
109.9%
5Y CAGR
29.9%
7Y CAGR
-12.3%
10Y CAGR
-4.1%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-96.5%
2Y CAGR
-83.8%
3Y CAGR
-73.3%
Total ShareHolders Funds Annual is falling faster than historical averages.

BioRestorative Therapies Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share BioRestorative Therapies Inc Book Value Per Share is $2 which is growth of -91.8% YoY.

  • NEUTRAL

    ROE BioRestorative Therapies Inc ROE is 0% which is growth of 0% YoY.

BioRestorative Therapies Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--72.15%-99.26%-95.12%-330.62%-387.82%-1,101.88%-848.38%-565.78%-480.19%-427.28%
ROE Ann. %
-
-
--89.56%-105.41%-98.91%-437.56%------
ROIC %
-
-
--19-22.9-26-170.3------
OPM Ann. %
-
-
-4,350.05%-2,881.59%-10,382.33%-15,745.83%-57,191.02%-3,574.13%-6,486.16%-6,889.77%-10,338.62%-21,444.61%-1,140.11%
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
-00000.10.10.100.3
Working Capital Turnover Ann.
-
-
-0.60.1000-0-0-0-0-0.1
Quick Ratio Ann.
-
-
-2.910.433.557.8300.100.1
Current Ratio Ann.
-
-
-310.734.4593.1000.100.1
Interest Coverage Ratio Ann.
-
-
-----23.4-5.9-1.9-2.9-7.7-10.3-29.1
LT Debt To Equity Ann.
-
-
---00------
*All financials are in USD Million and price data in USD
Add metric to table
Search...

BioRestorative Therapies Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity BioRestorative Therapies Inc Dec-2025 Cash From Operating Activity is $-11 Million which is growth of -31.1% YoY.

  • POSITIVE

    Net Cash Flow BioRestorative Therapies Inc Dec-2025 Net Cash Flow is $1 Million which is growth of 386.3% YoY.

BioRestorative Therapies Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
-10.8-8.2-6.4-5.9-3.3-2-6.9-5.1-3.9-5-3.1
⌄
-
-
8.90.53.3-13.5-0-0-0-0.2-0.5
⌄
-
-10.3%
2.97.42.421.356.84.84.35.13.7
Cash Plus Cash Eqv. End Of Year Ann.
-4.1%
-13.5%
1.50.60.91.7213.10.10.500.2
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-20.3%
1-0.3-0.8-19.4183.1-0.1-0.30.4-0.10.1
Cash Plus Cash Eqv. Begin Of Year Ann.
-69.4%
-
0.60.91.7213.10.10.500.20.1
Income Tax Paid Supplemental Data Ann.
-
-
-------
Interest Paid Supplemental Data Ann.
-
-
-0.400-00.1
Capex Ann.
-
-
-0.1-0.1-0.2-0.4-0--0-0-0.2-0.5
Issuance Of Capital Stock Ann.
-
-
3.12.421.101.70.21.13.52
Issuance Of Debt Ann.
-
-
---0.35.510.95.12.51.91.2
Repayment Of Debt Ann.
-
-
------5.7-0.9-0.3-0.5-0
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-10.9-8.3-6.6-6.3-3.4-2-7-5.1-3.9-5.2-3.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Investing Act. Ann.
1Y CHG
1680%
2Y CAGR
64.2%
Cash from Investing Activity Annual growth is higher than historical averages.
Cash from Financing Act. Ann.
1Y CHG
-60.8%
2Y CAGR
9.9%
5Y CAGR
-10.3%
7Y CAGR
-6.9%
10Y CAGR
-2.4%
Cash from Financing Annual Activity is falling faster than historical averages.
×